Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1995 Mar;63(3):984–988. doi: 10.1128/iai.63.3.984-988.1995

Degradation of humoral host defense by Candida albicans proteinase.

H Kaminishi 1, H Miyaguchi 1, T Tamaki 1, N Suenaga 1, M Hisamatsu 1, I Mihashi 1, H Matsumoto 1, H Maeda 1, Y Hagihara 1
PMCID: PMC173099  PMID: 7868271

Abstract

The effect of an extracellular proteinase from the pathogenic yeast Candida albicans on the bactericidal and opsonizing activities of human serum was studied. The ability of human polymorphonuclear leukocytes to kill Staphylococcus aureus was greatly reduced when the bacteria were opsonized with human serum treated with the proteinase. The reduction in the opsonizing activity of human serum was attributed to degradation of the Fc portion of immunoglobulin G by the action of C. albicans proteinase as determined by immunoprecipitation reaction. However, the Fab portion of immunoglobulin G was resistant to proteolysis by the proteinase. A clear reduction in the bactericidal activity of human serum against Escherichia coli was observed when the serum was treated with C. albicans proteinase. The reduction of serum bactericidal activity was attributed to the degradation of complement C3 by proteolysis by the proteinase as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, while C5 resisted the action of the proteinase. As determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the proteinase also degrades endogenous proteinase inhibitors, such as alpha 2 macroglobulin and alpha 1 proteinase inhibitor, which are involved in regulating inflammation. These results suggest that destruction of a host's defense-oriented or regulatory proteins facilitates debilitation of the infected host.

Full Text

The Full Text of this article is available as a PDF (271.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borg M., Rüchel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun. 1988 Mar;56(3):626–631. doi: 10.1128/iai.56.3.626-631.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cutler J. E. Putative virulence factors of Candida albicans. Annu Rev Microbiol. 1991;45:187–218. doi: 10.1146/annurev.mi.45.100191.001155. [DOI] [PubMed] [Google Scholar]
  3. Insler M. S., Urso L. F. Candida albicans endophthalmitis after penetrating keratoplasty. Am J Ophthalmol. 1987 Jul 15;104(1):57–60. doi: 10.1016/0002-9394(87)90293-5. [DOI] [PubMed] [Google Scholar]
  4. Kalmar J. R., Arnold R. R., Warbington M. L., Gardner M. K. Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J Immunol Methods. 1988 Jun 13;110(2):275–281. doi: 10.1016/0022-1759(88)90115-9. [DOI] [PubMed] [Google Scholar]
  5. Kamiike W., Fujikawa M., Koseki M., Sumimura J., Miyata M., Kawashima Y., Wada H., Tagawa K. Different patterns of leakage of cytosolic and mitochondrial enzymes. Clin Chim Acta. 1989 Dec 15;185(3):265–270. doi: 10.1016/0009-8981(89)90216-7. [DOI] [PubMed] [Google Scholar]
  6. Kaminishi H., Hagihara Y., Hayashi S., Cho T. Isolation and characteristics of collagenolytic enzyme produced by Candida albicans. Infect Immun. 1986 Aug;53(2):312–316. doi: 10.1128/iai.53.2.312-316.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaminishi H., Hagihara Y., Tanaka M., Cho T. Degradation of bovine achilles tendon collagen by Candida albicans proteinase. J Med Vet Mycol. 1988;26(5):315–318. [PubMed] [Google Scholar]
  8. Kaminishi H., Hamatake H., Cho T., Tamaki T., Suenaga N., Fujii T., Hagihara Y., Maeda H. Activation of blood clotting factors by microbial proteinases. FEMS Microbiol Lett. 1994 Sep 1;121(3):327–332. doi: 10.1111/j.1574-6968.1994.tb07121.x. [DOI] [PubMed] [Google Scholar]
  9. Kaminishi H., Tanaka M., Cho T., Maeda H., Hagihara Y. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect Immun. 1990 Jul;58(7):2139–2143. doi: 10.1128/iai.58.7.2139-2143.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klotz S. A., Drutz D. J., Harrison J. L., Huppert M. Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun. 1983 Oct;42(1):374–384. doi: 10.1128/iai.42.1.374-384.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kwon-Chung K. J., Lehman D., Good C., Magee P. T. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun. 1985 Sep;49(3):571–575. doi: 10.1128/iai.49.3.571-575.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Macdonald F., Odds F. C. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol. 1983 Feb;129(2):431–438. doi: 10.1099/00221287-129-2-431. [DOI] [PubMed] [Google Scholar]
  14. Maeda H., Maruo K., Akaike T., Kaminishi H., Hagiwara Y. Microbial proteinases as an universal trigger of kinin generation in microbial infections. Agents Actions Suppl. 1992;38(Pt 3):362–369. [PubMed] [Google Scholar]
  15. McLeish K. R., McMurray S. D., Smith E. J., Filo R. S. The transmission of Candida albicans by cadaveric allografts. J Urol. 1977 Oct;118(4):513–516. doi: 10.1016/s0022-5347(17)58089-1. [DOI] [PubMed] [Google Scholar]
  16. Molla A., Akaike T., Maeda H. Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens. Infect Immun. 1989 Jun;57(6):1868–1871. doi: 10.1128/iai.57.6.1868-1871.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Molla A., Kagimoto T., Maeda H. Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens. Infect Immun. 1988 Apr;56(4):916–920. doi: 10.1128/iai.56.4.916-920.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Molla A., Matsumura Y., Yamamoto T., Okamura R., Maeda H. Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin. Infect Immun. 1987 Oct;55(10):2509–2517. doi: 10.1128/iai.55.10.2509-2517.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Neely A. N., Holder I. A. Effect of proteolytic activity on virulence of Candida albicans in burned mice. Infect Immun. 1990 Jun;58(6):1527–1531. doi: 10.1128/iai.58.6.1527-1531.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Negi M., Tsuboi R., Matsui T., Ogawa H. Isolation and characterization of proteinase from Candida albicans: substrate specificity. J Invest Dermatol. 1984 Jul;83(1):32–36. doi: 10.1111/1523-1747.ep12261656. [DOI] [PubMed] [Google Scholar]
  21. Odds F. C. Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections. Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Dec;260(4):539–542. doi: 10.1016/s0176-6724(85)80069-9. [DOI] [PubMed] [Google Scholar]
  22. Prasad J. K., Feller I., Thomson P. D. A ten-year review of Candida sepsis and mortality in burn patients. Surgery. 1987 Feb;101(2):213–216. [PubMed] [Google Scholar]
  23. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Remold H., Fasold H., Staib F. Purification and characterization of a proteolytic enzyme from Candida albicans. Biochim Biophys Acta. 1968 Oct 8;167(2):399–406. doi: 10.1016/0005-2744(68)90219-2. [DOI] [PubMed] [Google Scholar]
  25. Rüchel R., Böning B. Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin. J Immunol Methods. 1983 Jun 24;61(1):107–116. doi: 10.1016/0022-1759(83)90014-5. [DOI] [PubMed] [Google Scholar]
  26. Rüchel R. Properties of a purified proteinase from the yeast Candida albicans. Biochim Biophys Acta. 1981 May 14;659(1):99–113. doi: 10.1016/0005-2744(81)90274-6. [DOI] [PubMed] [Google Scholar]
  27. Rüchel R., Uhlemann K., Böning B. Secretion of acid proteinases by different species of the genus Candida. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Nov;255(4):537–548. [PubMed] [Google Scholar]
  28. Rüchel R., Zimmermann F., Böning-Stutzer B., Helmchen U. Candidiasis visualised by proteinase-directed immunofluorescence. Virchows Arch A Pathol Anat Histopathol. 1991;419(3):199–202. doi: 10.1007/BF01626348. [DOI] [PubMed] [Google Scholar]
  29. Silverstein S. C., Steinman R. M., Cohn Z. A. Endocytosis. Annu Rev Biochem. 1977;46:669–722. doi: 10.1146/annurev.bi.46.070177.003321. [DOI] [PubMed] [Google Scholar]
  30. Staib F. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia. 1965 Oct;4(3):187–193. doi: 10.1080/00362176685190421. [DOI] [PubMed] [Google Scholar]
  31. Tsuobi R., Kurita Y., Negi M., Ogawa H. A specific inhibitor of keratinolytic proteinase from Candida albicans could inhibit the cell growth of C. albicans. J Invest Dermatol. 1985 Nov;85(5):438–440. doi: 10.1111/1523-1747.ep12277147. [DOI] [PubMed] [Google Scholar]
  32. Yasmeen D., Ellerson J. R., Dorrington K. J., Painter R. H. Evidence for the domain hypothesis: location of the site of cytophilic activity toward guinea pig macrophages in the C H 3 homology region of human immunoglobulin G. J Immunol. 1973 Jun;110(6):1706–1709. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES